Costs of people with diabetes in relation to average glucose control: an empirical approach controlling for year of onset cohorts.

HbA1c, insulin treatment and diabetes duration are the main drivers of increasing care costs. The results signal the relevance of controlling for HbA1c together with treatment modality, diabetes duration and year of diagnosis effects.